Goodwin houses a broad offering known for its strength in financing mandates, patent infringement actions, and co-development and distribution agreements. Anne-Charlotte Rivière heads the practice, and is recognised for her vast expertise in venture capital, private equity, and M&A work within the life sciences space, particularly in relation to fundraisings. Rivière assists both global and domestic life sciences venture funds. Marie Fillon leads the firm’s IP group, with her primary area of expertise being collaboration, R&D, and manufacturing agreements.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Marie Fillon has an excellent knowledge of the start-up/scale-up environment in France in the healthcare sector.’
‘Very experienced in our sector. Adaptable. Ability to work internationally with US or UK partners. This is important in M&A deals in the healthcare sector. Great brand and great involvement and thoroughness of the teams.’
‘Anne-Charlotte Rivière is experienced in corporate matters in France and internationally for financing operations or complex structured deals.’
‘Anne-Charlotte Rivière: global vision of the issues in the field of life sciences. Marie Fillon: highly valuable business vision.’
Kernmandanten
- Affluent Medical
- AlgoTx
- AQEMIA
- Arkhn
- Biomunex
- Cerba Healthcare
- DNA Script
- DentalMonitoring
- eCential Robotics
- Germitec
Anwält*innen
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Praxisleitung
Anne-Charlotte Rivière
Weitere Kernanwält*innen
Marie Fillon; Thomas Dupont-Sentilles; Louis de Chezelles